Comparison of Different Measurements of Intestinal Permeability in Inflammatory Bowel Disease

Colin Howden, C. Robertson, A. Duncan, A. J. Morris, R. I. Russell

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

We have compared different measurements of small intestinal permeability in 28 patients with Crohn's disease affecting the small intestine, 14 with ulcerative colitis and 17 controls. Patients and controls were given a drink containing 100 μCi (3.7 MBq) of 51Cr‐ethylene diamine tetraacetic acid (51Cr‐EDTA), 5 g lactulose, 5 g cellobiose, 1 g rhamnose, and 2 g mannitol. Urine was collected to 6 h after dosing, and then from 6 until 24 h. Recoveries of 51Cr‐EDTA, lactulose, rbamnose, and mannitol were expressed as percentages of the amount administered. The only measurement that distinguished patients with Crohn's disease from both controls and patients with ulcerative colitis was the recovery of 51Cr‐EDTA in the first 6 h after dosing. The mean recovery in patients with Crohn's disease was 1.07%; in controls, it was 0.35% (p= 0.013); in ulcerative colitis it was 0.39% (p= 0.032 compared to Crohn's; p= 0.492 compared to controls). No other measurement of permeability differentiated the three groups. Recoveries of 51Cr‐EDTA and lactulose were highly correlated in each of the three groups. Recovery of rhamnose was significantly correlated with that of mannitol. In the patients with Crohn's disease, recovery of 51Cr‐EDTA to 6 h was significantly correlated with some nonspecific laboratory indicators of inflammatory activity, namely, erythrocyte sedimentation rate, platelet count, white blood cell count, serum albumin, and C‐reactive protein, but not with hemoglobin.

Original languageEnglish (US)
Pages (from-to)1445-1449
Number of pages5
JournalThe American Journal of Gastroenterology
Volume86
Issue number10
DOIs
StatePublished - Jan 1 1991
Externally publishedYes

Fingerprint

Diamines
Inflammatory Bowel Diseases
Permeability
Lactulose
Crohn Disease
Mannitol
Acids
Ulcerative Colitis
Rhamnose
Cellobiose
Blood Sedimentation
Platelet Count
Leukocyte Count
Serum Albumin
Small Intestine
Hemoglobins
Urine
Proteins

All Science Journal Classification (ASJC) codes

  • Hepatology
  • Gastroenterology

Cite this

Comparison of Different Measurements of Intestinal Permeability in Inflammatory Bowel Disease. / Howden, Colin; Robertson, C.; Duncan, A.; Morris, A. J.; Russell, R. I.

In: The American Journal of Gastroenterology, Vol. 86, No. 10, 01.01.1991, p. 1445-1449.

Research output: Contribution to journalArticle

Howden, Colin ; Robertson, C. ; Duncan, A. ; Morris, A. J. ; Russell, R. I. / Comparison of Different Measurements of Intestinal Permeability in Inflammatory Bowel Disease. In: The American Journal of Gastroenterology. 1991 ; Vol. 86, No. 10. pp. 1445-1449.
@article{d724835b75554b5c927fc3d48439d9f2,
title = "Comparison of Different Measurements of Intestinal Permeability in Inflammatory Bowel Disease",
abstract = "We have compared different measurements of small intestinal permeability in 28 patients with Crohn's disease affecting the small intestine, 14 with ulcerative colitis and 17 controls. Patients and controls were given a drink containing 100 μCi (3.7 MBq) of 51Cr‐ethylene diamine tetraacetic acid (51Cr‐EDTA), 5 g lactulose, 5 g cellobiose, 1 g rhamnose, and 2 g mannitol. Urine was collected to 6 h after dosing, and then from 6 until 24 h. Recoveries of 51Cr‐EDTA, lactulose, rbamnose, and mannitol were expressed as percentages of the amount administered. The only measurement that distinguished patients with Crohn's disease from both controls and patients with ulcerative colitis was the recovery of 51Cr‐EDTA in the first 6 h after dosing. The mean recovery in patients with Crohn's disease was 1.07{\%}; in controls, it was 0.35{\%} (p= 0.013); in ulcerative colitis it was 0.39{\%} (p= 0.032 compared to Crohn's; p= 0.492 compared to controls). No other measurement of permeability differentiated the three groups. Recoveries of 51Cr‐EDTA and lactulose were highly correlated in each of the three groups. Recovery of rhamnose was significantly correlated with that of mannitol. In the patients with Crohn's disease, recovery of 51Cr‐EDTA to 6 h was significantly correlated with some nonspecific laboratory indicators of inflammatory activity, namely, erythrocyte sedimentation rate, platelet count, white blood cell count, serum albumin, and C‐reactive protein, but not with hemoglobin.",
author = "Colin Howden and C. Robertson and A. Duncan and Morris, {A. J.} and Russell, {R. I.}",
year = "1991",
month = "1",
day = "1",
doi = "10.1111/j.1572-0241.1991.tb06870.x",
language = "English (US)",
volume = "86",
pages = "1445--1449",
journal = "American Journal of Gastroenterology",
issn = "0002-9270",
publisher = "Nature Publishing Group",
number = "10",

}

TY - JOUR

T1 - Comparison of Different Measurements of Intestinal Permeability in Inflammatory Bowel Disease

AU - Howden, Colin

AU - Robertson, C.

AU - Duncan, A.

AU - Morris, A. J.

AU - Russell, R. I.

PY - 1991/1/1

Y1 - 1991/1/1

N2 - We have compared different measurements of small intestinal permeability in 28 patients with Crohn's disease affecting the small intestine, 14 with ulcerative colitis and 17 controls. Patients and controls were given a drink containing 100 μCi (3.7 MBq) of 51Cr‐ethylene diamine tetraacetic acid (51Cr‐EDTA), 5 g lactulose, 5 g cellobiose, 1 g rhamnose, and 2 g mannitol. Urine was collected to 6 h after dosing, and then from 6 until 24 h. Recoveries of 51Cr‐EDTA, lactulose, rbamnose, and mannitol were expressed as percentages of the amount administered. The only measurement that distinguished patients with Crohn's disease from both controls and patients with ulcerative colitis was the recovery of 51Cr‐EDTA in the first 6 h after dosing. The mean recovery in patients with Crohn's disease was 1.07%; in controls, it was 0.35% (p= 0.013); in ulcerative colitis it was 0.39% (p= 0.032 compared to Crohn's; p= 0.492 compared to controls). No other measurement of permeability differentiated the three groups. Recoveries of 51Cr‐EDTA and lactulose were highly correlated in each of the three groups. Recovery of rhamnose was significantly correlated with that of mannitol. In the patients with Crohn's disease, recovery of 51Cr‐EDTA to 6 h was significantly correlated with some nonspecific laboratory indicators of inflammatory activity, namely, erythrocyte sedimentation rate, platelet count, white blood cell count, serum albumin, and C‐reactive protein, but not with hemoglobin.

AB - We have compared different measurements of small intestinal permeability in 28 patients with Crohn's disease affecting the small intestine, 14 with ulcerative colitis and 17 controls. Patients and controls were given a drink containing 100 μCi (3.7 MBq) of 51Cr‐ethylene diamine tetraacetic acid (51Cr‐EDTA), 5 g lactulose, 5 g cellobiose, 1 g rhamnose, and 2 g mannitol. Urine was collected to 6 h after dosing, and then from 6 until 24 h. Recoveries of 51Cr‐EDTA, lactulose, rbamnose, and mannitol were expressed as percentages of the amount administered. The only measurement that distinguished patients with Crohn's disease from both controls and patients with ulcerative colitis was the recovery of 51Cr‐EDTA in the first 6 h after dosing. The mean recovery in patients with Crohn's disease was 1.07%; in controls, it was 0.35% (p= 0.013); in ulcerative colitis it was 0.39% (p= 0.032 compared to Crohn's; p= 0.492 compared to controls). No other measurement of permeability differentiated the three groups. Recoveries of 51Cr‐EDTA and lactulose were highly correlated in each of the three groups. Recovery of rhamnose was significantly correlated with that of mannitol. In the patients with Crohn's disease, recovery of 51Cr‐EDTA to 6 h was significantly correlated with some nonspecific laboratory indicators of inflammatory activity, namely, erythrocyte sedimentation rate, platelet count, white blood cell count, serum albumin, and C‐reactive protein, but not with hemoglobin.

UR - http://www.scopus.com/inward/record.url?scp=0026085193&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026085193&partnerID=8YFLogxK

U2 - 10.1111/j.1572-0241.1991.tb06870.x

DO - 10.1111/j.1572-0241.1991.tb06870.x

M3 - Article

VL - 86

SP - 1445

EP - 1449

JO - American Journal of Gastroenterology

JF - American Journal of Gastroenterology

SN - 0002-9270

IS - 10

ER -